Works by Terkeltaub, Robert

Results: 105

Impact of adding urine alkalization therapy to xanthine oxidase inhibitor in gout management: a prospective cohort study Open Access.

Published in:

Rheumatology, 2025, v. 64, n. 6, p. 3509, doi. 10.1093/rheumatology/keaf091

By:

Wang, Can;
Guo, Kai;
Dalbeth, Nicola;
Sun, Mingshu;
Lu, Jie;
Chen, Ying;
Zhang, Hui;
Wang, Xuefeng;
Ji, Xiaopeng;
Li, Xinde;
Sun, Wenyan;
Han, Lin;
Cui, Lingling;
Liu, Zhen;
Ji, Aichang;
He, Yuwei;
Terkeltaub, Robert;
Li, Changgui

Publication type:

Article

An artificial intelligence-based gout management system reduced chronic kidney disease incident and improved target serum urate achievement.

Published in:

Rheumatology, 2025, v. 64, n. 5, p. 3048, doi. 10.1093/rheumatology/keae616

By:

Qi, Han;
Lu, Jie;
Dalbeth, Nicola;
Sun, Mingshu;
Liu, Zhen;
Ji, Xiaopeng;
Ji, Aichang;
Wang, Can;
Sun, Wenyan;
Li, Xinde;
He, Yuwei;
Cui, Lingling;
Han, Lin;
Chen, Ying;
Yan, Fei;
Zhang, Yi;
Terkeltaub, Robert;
Li, Changgui

Publication type:

Article

The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout.

Published in:

Rheumatology, 2024, v. 63, n. 4, p. 1058, doi. 10.1093/rheumatology/kead333

By:

Baraf, Herbert S B;
Khanna, Puja P;
Kivitz, Alan J;
Strand, Vibeke;
Choi, Hyon K;
Terkeltaub, Robert;
Dalbeth, Nicola;
DeHaan, Wesley;
Azeem, Rehan;
Traber, Peter G;
Keenan, Robert T

Publication type:

Article

Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort study.

Published in:

Rheumatology, 2023, v. 62, n. 7, p. 2435, doi. 10.1093/rheumatology/keac656

By:

Hu, Shuhui;
Sun, Mingshu;
Li, Maichao;
Xue, Xiaomei;
Terkeltaub, Robert;
Wang, Can;
Wang, Ming;
Lu, Jie;
Ran, Zijing;
Li, Hailong;
Ji, Aichang;
Sun, Wenyan;
Li, Xinde;
He, Yuwei;
Liu, Zhen;
Zhang, Hui;
Wang, Xuefeng;
Ji, Xiaopeng;
Dalbeth, Nicola;
Li, Changgui

Publication type:

Article

Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of gout.

Published in:

Rheumatology, 2019, v. 58, n. 1, p. 61, doi. 10.1093/rheumatology/key245

By:

Terkeltaub, Robert;
Saag, Kenneth G;
Goldfarb, David S;
Baumgartner, Scott;
Schechter, Bruce M;
Valiyil, Ritu;
Jalal, Diana;
Pillinger, Michael;
White, William B

Publication type:

Article

PPARGC1B: insight into the expression of the gouty inflammation phenotype.

Published in:

2017

By:

Merriman, Tony;
Terkeltaub, Robert

Publication type:

Editorial

Allopurinol Initiation and All-Cause Mortality Among Patients With Gout and Concurrent Chronic Kidney Disease : A Population-Based Cohort Study.

Published in:

2022

By:

Wei, Jie;
Choi, Hyon K.;
Neogi, Tuhina;
Dalbeth, Nicola;
Terkeltaub, Robert;
Stamp, Lisa K.;
Lyu, Houchen;
McCormick, Natalie;
Niu, Jingbo;
Zeng, Chao;
Lei, Guanghua;
Zhang, Yuqing

Publication type:

journal article

The Evolving Landscape of Gout in the Female: A Narrative Review.

Published in:

Gout, Urate, & Crystal Deposition Disease, 2024, v. 2, n. 1, p. 1, doi. 10.3390/gucdd2010001

By:

Lee, Jennifer;
Sumpter, Nicholas;
Merriman, Tony R.;
Liu-Bryan, Ru;
Terkeltaub, Robert

Publication type:

Article

Atherogenic Activation of Human Vascular Smooth Muscle Cells by Monosodium Urate Crystals.

Published in:

Gout, Urate, & Crystal Deposition Disease, 2023, v. 1, n. 3, p. 192, doi. 10.3390/gucdd1030016

By:

Liu-Bryan, Ru;
Guo, Tracy;
Lee, Jennifer;
Terkeltaub, Robert

Publication type:

Article

Proteoglycan 4 (PRG4)/Lubricin and the Extracellular Matrix in Gout.

Published in:

Gout, Urate, & Crystal Deposition Disease, 2023, v. 1, n. 3, p. 122, doi. 10.3390/gucdd1030012

By:

Elsaid, Khaled A.;
Jay, Gregory D.;
Liu-Bryan, Ru;
Terkeltaub, Robert

Publication type:

Article

Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemia.

Published in:

Nephrology Dialysis Transplantation, 2022, v. 37, n. 8, p. 1461, doi. 10.1093/ndt/gfab237

By:

Heerspink, Hiddo J L;
Stack, Austin G;
Terkeltaub, Robert;
Greene, Tom A;
Inker, Lesley A;
Bjursell, Magnus;
Perl, Shira;
Rikte, Tord;
Erlandsson, Fredrik;
Perkovic, Vlado

Publication type:

Article

Effective xanthine oxidase inhibitor urate lowering therapy in gout is linked to an emergent serum protein interactome of complement and inflammation modulators.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-74154-5

By:

Sanchez, Concepcion;
Campeau, Anaamika;
Liu-Bryan, Ru;
Mikuls, Ted R.;
O'Dell, James R.;
Gonzalez, David J.;
Terkeltaub, Robert

Publication type:

Article

Gout in 2006.

Published in:

Bulletin of the NYU Hospital for Joint Diseases, 2006, v. 64, n. 1/2, p. 82

By:

Terkeltaub, Robert

Publication type:

Article

Nanocapsules of oxalate oxidase for hyperoxaluria treatment.

Published in:

Nano Research, 2018, v. 11, n. 5, p. 2682, doi. 10.1007/s12274-017-1898-3

By:

Zhao, Ming;
Xu, Duo;
Wu, Di;
Whittaker, James W.;
Terkeltaub, Robert;
Lu, Yunfeng

Publication type:

Article

Feasibility of conducting a randomized, placebo-controlled study assessing whether omega-3 fatty acids prevent gout flares when starting urate-lowering treatment.

Published in:

Rheumatology Advances in Practice, 2022, v. 6, n. 3, p. 1, doi. 10.1093/rap/rkac086

By:

Abhishek, Abhishek;
Fuller, Amy;
Nakafero, Georgina;
Zhang, Weiya;
Dumbleton, Jennifer;
Hawkey, Christopher;
Coupland, Carol;
Terkeltaub, Robert;
Doherty, Michael

Publication type:

Article

Predictors of doctor-rated and patient-rated gout severity: gout impact scales improve assessment.

Published in:

Journal of Evaluation in Clinical Practice, 2010, v. 16, n. 6, p. 1244, doi. 10.1111/j.1365-2753.2009.01303.x

By:

Sarkin, Andrew J.;
Levack, Ashley E.;
Shieh, Marian M.;
Kavanaugh, Arthur F.;
Khanna, Dinesh;
Singh, Jasvinder A.;
Terkeltaub, Robert A.;
Lee, Susan J.;
Hirsch, Jan D.

Publication type:

Article

Patients Prescribed Anakinra for Acute Gout Have Baseline Increased Burden of Hyperuricemia, Tophi, and Comorbidities, and Ultimate All-Cause Mortality.

Published in:

Clinical Medicine Insights: Arthritis & Musculoskeletal Disorders, 2019, v. 12, p. N.PAG, doi. 10.1177/1179544119890853

By:

Sharma, Ena;
Pedersen, Brian;
Terkeltaub, Robert

Publication type:

Article

Arhalofenate acid inhibits monosodium urate crystal-induced inflammatory responses through activation of AMP-activated protein kinase (AMPK) signaling.

Published in:

Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1699-4

By:

McWherter, Charles;
Choi, Yun-Jung;
Serrano, Ramon L.;
Mahata, Sushil K.;
Terkeltaub, Robert;
Liu-Bryan, Ru

Publication type:

Article

Dose-response relationship between lower serum magnesium level and higher prevalence of knee chondrocalcinosis.

Published in:

Arthritis Research & Therapy, 2017, v. 19, p. 1, doi. 10.1186/s13075-017-1450-6

By:

Chao Zeng;
Jie Wei;
Terkeltaub, Robert;
Tuo Yang;
Choi, Hyon K.;
Yi-lun Wang;
Dong-xing Xie;
Hunter, David J.;
Yuqing Zhang;
Hui Li;
Yang Cui;
Liang-jun Li;
Guang-hua Lei

Publication type:

Article

Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney.

Published in:

Arthritis Research & Therapy, 2016, v. 18, p. 1, doi. 10.1186/s13075-016-1107-x

By:

Miner, Jeffrey;
Tan, Philip K.;
Hyndman, David;
Sha Liu;
Iverson, Cory;
Nanavati, Payal;
Hagerty, David T.;
Manhard, Kimberly;
Zancong Shen;
Girardet, Jean-Luc;
Li-Tain Yeh;
Terkeltaub, Robert;
Quart, Barry

Publication type:

Article

Npp1 promotes atherosclerosis in ApoE knockout mice.

Published in:

Journal of Cellular & Molecular Medicine, 2011, v. 15, n. 11, p. 2273, doi. 10.1111/j.1582-4934.2011.01327.x

By:

Nitschke, Yvonne;
Weissen-Plenz, Gabriele;
Terkeltaub, Robert;
Rutsch, Frank

Publication type:

Article

Arterial Calcification Is Driven by RAGE in Enpp1-/- Mice.

Published in:

Journal of Vascular Research, 2011, v. 48, n. 3, p. 227, doi. 10.1159/000318805

By:

Cecil, Denise L.;
Terkeltaub, Robert A.

Publication type:

Article

Sex differences in gout characteristics: tailoring care for women and men.

Published in:

2017

By:

Harrold, Leslie R.;
Etzel, Carol J.;
Gibofsky, Allan;
Kremer, Joel M.;
Pillinger, Michael H.;
Saag, Kenneth G.;
Schlesinger, Naomi;
Terkeltaub, Robert;
Cox, Vanessa;
Greenberg, Jeffrey D.

Publication type:

journal article

Novel Genetic Loci in Early‐Onset Gout Derived From Whole‐Genome Sequencing of an Adolescent Gout Cohort.

Published in:

Arthritis & Rheumatology, 2025, v. 77, n. 1, p. 107, doi. 10.1002/art.42969

By:

Ji, Aichang;
Sui, Yang;
Xue, Xiaomei;
Ji, Xiapeng;
Shi, Wenrui;
Shi, Yongyong;
Terkeltaub, Robert;
Dalbeth, Nicola;
Takei, Riku;
Yan, Fei;
Sun, Mingshu;
Li, Maichao;
Lu, Jie;
Cui, Lingling;
Liu, Zhen;
Wang, Can;
Li, Xinde;
Han, Lin;
Fang, Zhanjie;
Sun, Wenyan

Publication type:

Article

Hyperuricemia Subtypes Classified According to Renal Uric Acid Handling Manifesting Distinct Phenotypic and Genetic Profiles in People With Gout.

Published in:

Arthritis & Rheumatology, 2024, v. 76, n. 7, p. 1130, doi. 10.1002/art.42838

By:

Qi, Han;
Sun, Mingshu;
Terkeltaub, Robert;
Merriman, Tony R.;
Chen, Haibing;
Li, Zhiqiang;
Ji, Aichang;
Xue, Xiaomei;
Sun, Wenyan;
Wang, Can;
Li, Xinde;
He, Yuwei;
Cui, Lingling;
Dalbeth, Nicola;
Li, Changgui

Publication type:

Article

Metabolomics and Machine Learning Identify Metabolic Differences and Potential Biomarkers for Frequent Versus Infrequent Gout Flares.

Published in:

Arthritis & Rheumatology, 2023, v. 75, n. 12, p. 2252, doi. 10.1002/art.42635

By:

Wang, Ming;
Li, Rui;
Qi, Han;
Pang, Lei;
Cui, Lingling;
Liu, Zhen;
Lu, Jie;
Wang, Rong;
Hu, Shuhui;
Liang, Ningning;
Tao, Yongzhen;
Dalbeth, Nicola;
Merriman, Tony R.;
Terkeltaub, Robert;
Yin, Huiyong;
Li, Changgui

Publication type:

Article

Prediagnostic Glycoprotein Acetyl Levels and Incident and Recurrent Flare Risk Accounting for Serum Urate Levels: A Population‐Based, Prospective Study and Mendelian Randomization Analysis.

Published in:

Arthritis & Rheumatology, 2023, v. 75, n. 9, p. 1648, doi. 10.1002/art.42523

By:

Joshi, Amit D.;
McCormick, Natalie;
Yokose, Chio;
Yu, Bing;
Tin, Adrienne;
Terkeltaub, Robert;
Merriman, Tony R.;
Eliassen, A. Heather;
Curhan, Gary C.;
Raffield, Laura M.;
Choi, Hyon K.

Publication type:

Article

Serum Urate–Lowering Efficacy and Safety of Tigulixostat in Gout Patients With Hyperuricemia: A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Finding Trial.

Published in:

Arthritis & Rheumatology, 2023, v. 75, n. 7, p. 1275, doi. 10.1002/art.42447

By:

Terkeltaub, Robert;
Lee, Jisoo;
Min, Jiyoung;
Shin, Seonghye;
Saag, Kenneth G.

Publication type:

Article

Superiority of Low‐Dose Benzbromarone to Low‐Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion.

Published in:

Arthritis & Rheumatology, 2022, v. 74, n. 12, p. 2015, doi. 10.1002/art.42266

By:

Yan, Fei;
Xue, Xiaomei;
Lu, Jie;
Dalbeth, Nicola;
Qi, Han;
Yu, Qing;
Wang, Can;
Sun, Mingshu;
Cui, Lingling;
Liu, Zhen;
He, Yuwei;
Yuan, Xuan;
Chen, Ying;
Cheng, Xiaoyu;
Ma, Lidan;
Li, Hailong;
Ji, Aichang;
Hu, Shuhui;
Ran, Zijing;
Terkeltaub, Robert

Publication type:

Article

Association Between Gut Microbiota and Elevated Serum Urate in Two Independent Cohorts.

Published in:

Arthritis & Rheumatology, 2022, v. 74, n. 4, p. 682, doi. 10.1002/art.42009

By:

Wei, Jie;
Zhang, Yuqing;
Dalbeth, Nicola;
Terkeltaub, Robert;
Yang, Tuo;
Wang, Yilun;
Yang, Zidan;
Li, Jiatian;
Wu, Ziying;
Zeng, Chao;
Lei, Guanghua

Publication type:

Article

Serum Metabolomics Identifies Dysregulated Pathways and Potential Metabolic Biomarkers for Hyperuricemia and Gout.

Published in:

Arthritis & Rheumatology, 2021, v. 73, n. 9, p. 1738, doi. 10.1002/art.41733

By:

Shen, Xia;
Wang, Can;
Liang, Ningning;
Liu, Zhen;
Li, Xinde;
Zhu, Zheng‐Jiang;
Merriman, Tony R.;
Dalbeth, Nicola;
Terkeltaub, Robert;
Li, Changgui;
Yin, Huiyong

Publication type:

Article

A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout Flares.

Published in:

Arthritis & Rheumatology, 2021, v. 73, n. 8, p. 1533, doi. 10.1002/art.41699

By:

Saag, Kenneth G.;
Khanna, Puja P.;
Keenan, Robert T.;
Ohlman, Sven;
Osterling Koskinen, Lisa;
Sparve, Erik;
Åkerblad, Ann‐Charlotte;
Wikén, Margareta;
So, Alexander;
Pillinger, Michael H.;
Terkeltaub, Robert

Publication type:

Article

Reassessing the Cardiovascular Safety of Febuxostat: Implications of the Febuxostat versus Allopurinol Streamlined Trial.

Published in:

Arthritis & Rheumatology, 2021, v. 73, n. 5, p. 721, doi. 10.1002/art.41638

By:

Choi, Hyon K.;
Neogi, Tuhina;
Stamp, Lisa K.;
Terkeltaub, Robert;
Dalbeth, Nicola

Publication type:

Article

Differential DNA Methylation of Networked Signaling, Transcriptional, Innate and Adaptive Immunity, and Osteoclastogenesis Genes and Pathways in Gout.

Published in:

Arthritis & Rheumatology, 2020, v. 72, n. 5, p. 802, doi. 10.1002/art.41173

By:

Wang, Zengmiao;
Zhao, Ying;
Phipps‐Green, Amanda;
Liu‐Bryan, Ru;
Ceponis, Arnoldas;
Boyle, David L.;
Wang, Jun;
Merriman, Tony R.;
Wang, Wei;
Terkeltaub, Robert

Publication type:

Article

Reply.

Published in:

2019

By:

Choi, Hyon;
Neogi, Tuhina;
Stamp, Lisa;
Dalbeth, Nicola;
Terkeltaub, Robert

Publication type:

Letter to the Editor

Effect of Dietary and Supplemental Omega‐3 Polyunsaturated Fatty Acids on Risk of Recurrent Gout Flares.

Published in:

Arthritis & Rheumatology, 2019, v. 71, n. 9, p. 1580, doi. 10.1002/art.40896

By:

Zhang, MaryAnn;
Zhang, Yuqing;
Terkeltaub, Robert;
Chen, Clara;
Neogi, Tuhina

Publication type:

Article

Reply.

Published in:

Arthritis & Rheumatology, 2019, v. 71, n. 3, p. 481, doi. 10.1002/art.40742

By:

Choi, Hyon;
Neogi, Tuhina;
Stamp, Lisa;
Dalbeth, Nicola;
Terkeltaub, Robert

Publication type:

Article

New Perspectives in Rheumatology: Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial and the Associated Food and Drug Administration Public Safety Alert.

Published in:

Arthritis & Rheumatology, 2018, v. 70, n. 11, p. 1702, doi. 10.1002/art.40583

By:

Choi, Hyon;
Neogi, Tuhina;
Stamp, Lisa;
Dalbeth, Nicola;
Terkeltaub, Robert

Publication type:

Article

Review: Unmet Needs and the Path Forward in Joint Disease Associated With Calcium Pyrophosphate Crystal Deposition.

Published in:

Arthritis & Rheumatology, 2018, v. 70, n. 8, p. 1182, doi. 10.1002/art.40517

By:

Abhishek, Abhishek;
Doherty, Michael;
Neogi, Tuhina;
Choi, Hyon;
Rosenthal, Ann K.;
Terkeltaub, Robert

Publication type:

Article

Impaired Proteasomal Function in Human Osteoarthritic Chondrocytes Can Contribute to Decreased Levels of SOX9 and Aggrecan.

Published in:

Arthritis & Rheumatology, 2018, v. 70, n. 7, p. 1030, doi. 10.1002/art.40456

By:

Serrano, Ramon L.;
Chen, Liang‐Yu;
Lotz, Martin K.;
Liu‐Bryan, Ru;
Terkeltaub, Robert

Publication type:

Article

Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial.

Published in:

Arthritis & Rheumatology, 2017, v. 69, n. 9, p. 1903, doi. 10.1002/art.40159

By:

Dalbeth, Nicola;
Jones, Graeme;
Terkeltaub, Robert;
Khanna, Dinesh;
Kopicko, Jeff;
Bhakta, Nihar;
Adler, Scott;
Fung, Maple;
Storgard, Chris;
Baumgartner, Scott;
Perez‐Ruiz, Fernando

Publication type:

Article

Review: Gout: A Roadmap to Approaches for Improving Global Outcomes.

Published in:

Arthritis & Rheumatology, 2017, v. 69, n. 1, p. 22, doi. 10.1002/art.39799

By:

Dalbeth, Nicola;
Choi, Hyon K.;
Terkeltaub, Robert

Publication type:

Article

Mitochondrial Biogenesis Is Impaired in Osteoarthritis Chondrocytes but Reversible via Peroxisome Proliferator-Activated Receptor γ Coactivator 1α.

Published in:

2015

By:

Wang, Yun;
Zhao, Xianling;
Lotz, Martin;
Terkeltaub, Robert;
Liu-Bryan, Ru

Publication type:

Journal Article

Mitochondrial Biogenesis Is Impaired in Osteoarthritis Chondrocytes but Reversible via Peroxisome Proliferator-Activated Receptor γ Coactivator 1α.

Published in:

Arthritis & Rheumatology, 2015, v. 67, n. 8, p. 2141, doi. 10.1002/art.39182

By:

Wang, Yun;
Zhao, Xianling;
Lotz, Martin;
Terkeltaub, Robert;
Liu‐Bryan, Ru

Publication type:

Article

Editorial: Can GPR43 Sensing of Short-Chain Fatty Acids Unchain Inflammasome-Driven Arthritis?

Published in:

Arthritis & Rheumatology, 2015, v. 67, n. 6, p. 1419, doi. 10.1002/art.39102

By:

Haslberger, Alexander;
Terkeltaub, Robert

Publication type:

Article

Peroxisome Proliferator-Activated Receptor γ Coactivator 1α and FoxO3A Mediate Chondroprotection by AMP-Activated Protein Kinase.

Published in:

2014

By:

Zhao, Xianling;
Petursson, Freyr;
Viollet, Benoit;
Lotz, Martin;
Terkeltaub, Robert;
Liu-Bryan, Ru

Publication type:

Journal Article

Peroxisome Proliferator-Activated Receptor γ Coactivator 1α and FoxO3A Mediate Chondroprotection by AMP-Activated Protein Kinase.

Published in:

Arthritis & Rheumatology, 2014, v. 66, n. 11, p. 3073, doi. 10.1002/art.38791

By:

Zhao, Xianling;
Petursson, Freyr;
Viollet, Benoit;
Lotz, Martin;
Terkeltaub, Robert;
Liu‐Bryan, Ru

Publication type:

Article

Enzyme Replacement Therapy for Murine Hypophosphatasia.

Published in:

Journal of Bone & Mineral Research, 2008, v. 23, n. 6, p. 777, doi. 10.1359/jbmr.071213

By:

Millán, José Luis;
Narisawa, Sonoko;
Lemire, Isabelle;
Loisel, Thomas P.;
Boileau, Guy;
Leonard, Pierre;
Gramatikova, Svetlana;
Terkeltaub, Robert;
Camacho, Nancy Pleshko;
Mckee, Marc D.;
Crine, Philippe;
Whyte, Michael P.

Publication type:

Article

Novel Mouse Model of Autosomal Semidominant Adult Hypophosphatasia Has a Splice Site Mutation in the Tissue Nonspecific Alkaline Phosphatase Gene Akp2.

Published in:

Journal of Bone & Mineral Research, 2007, v. 22, n. 9, p. 1397, doi. 10.1359/JBMR.070515

By:

Hough, Tertius A.;
Polewski, Monika;
Johnson, Kristen;
Cheeseman, Michael;
Nolan, Patrick M.;
Vizor, Lucie;
Rastan, Sohaila;
Boyde, Alan;
Pritzker, Kenneth;
Hunter, A. Jackie;
Fisher, Elizabeth M.C.;
Terkeltaub, Robert;
Brown, Steve D.M.

Publication type:

Article

Elevated Skeletal Osteopontin Levels Contribute to the Hypophosphatasia Phenotype in Akp2<sup>−/−</sup> Mice.

Published in:

Journal of Bone & Mineral Research, 2006, v. 21, n. 9, p. 1377, doi. 10.1359/jbmr.060619

By:

Harmey, Dympna;
Johnson, Kristen A;
Zelken, Jonathan;
Camacho, Nancy P;
Hoylaerts, Marc F;
Noda, Masaki;
Terkeltaub, Robert;
Millán, José Luis

Publication type:

Article